Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Diagnos Laboratorium Utama PT Tbk
Other Items
Diagnos Laboratorium Utama PT Tbk
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
Other Items
-Rp3.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
Other Items
Rp199.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Diagnos Laboratorium Utama PT Tbk
Glance View
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.
See Also
What is Diagnos Laboratorium Utama PT Tbk's Other Items?
Other Items
-3.9B
IDR
Based on the financial report for Dec 31, 2024, Diagnos Laboratorium Utama PT Tbk's Other Items amounts to -3.9B IDR.
What is Diagnos Laboratorium Utama PT Tbk's Other Items growth rate?
Other Items CAGR 5Y
32%
Over the last year, the Other Items growth was 0%. The average annual Other Items growth rates for Diagnos Laboratorium Utama PT Tbk have been 21% over the past three years , 32% over the past five years .
